See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / Ticker: LLY

Ticker: LLY
05:03am, Monday, Aug 19, 2024
Eli Lilly's Zepbound: The Game-Changer Poised to Steal Market Share in the $100 Billion Obesity Treatment Race
Eli Lilly's Zepbound, a groundbreaking GLP-1 agonist, is quickly becoming a blockbuster, complementing Mounjaro and competing with Novo Nordisk. With the obesity treatment market expected to reach $100 billion by 2030, Eli Lilly is a compelling long-term investment.
Read More